ondansetron has been researched along with Respiration Disorders in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortés-Flores, AO | 1 |
Jiménez-Tornero, J | 1 |
Morgan-Villela, G | 1 |
Delgado-Gómez, M | 1 |
Zuloaga-Fernández Del Valle, CJ | 1 |
García-Rentería, J | 1 |
Rendón-Félix, J | 1 |
Fuentes-Orozco, C | 1 |
Macías-Amezcua, MD | 1 |
Ambriz-González, G | 1 |
Alvarez-Villaseñor, AS | 1 |
Urias-Valdez, D | 1 |
Chavez-Tostado, M | 1 |
Contreras-Hernández, GI | 1 |
González-Ojeda, A | 1 |
1 trial available for ondansetron and Respiration Disorders
Article | Year |
---|---|
Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: Results of a controlled clinical trial.
Topics: Adenocarcinoma; Adult; Aged; Analgesics, Opioid; Antiemetics; Breast Neoplasms; Dexamethasone; Doubl | 2018 |